Animal models showed that genetic ablation of IFN-α/β receptor (IFNAR) depletion protected from lethal infection, without affecting viral load [70], suggesting that IFNs therapy may be effective mainly in the early stage of infection. The gene discussed is IFNAR1; the disease is infection.